Glycogen storage disease type II pathophysiology: Difference between revisions
No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Glycogen storage disease type II}} | {{Glycogen storage disease type II}} | ||
{{CMG}} | {{CMG}}; {{AE}} | ||
{{PleaseHelp}} | |||
==Overview== | ==Overview== | ||
==Pathophysiology== | ==Pathophysiology== | ||
The build-up of glycogen causes progressive muscle weakness ([[myopathy]]) throughout the body and affects various body tissues, particularly in the [[heart]], [[skeletal muscle]]s, [[liver]] and [[nervous system]]. | The build-up of glycogen causes progressive muscle weakness ([[myopathy]]) throughout the body and affects various body tissues, particularly in the [[heart]], [[skeletal muscle]]s, [[liver]] and [[nervous system]]. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
{{WS}} | |||
{{WH}} |
Revision as of 14:51, 19 July 2016
Glycogen storage disease type II Microchapters |
Differentiating Glycogen storage disease type II from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type II pathophysiology On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type II pathophysiology |
Glycogen storage disease type II pathophysiology in the news |
Directions to Hospitals Treating Glycogen storage disease type II |
Risk calculators and risk factors for Glycogen storage disease type II pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Pathophysiology
The build-up of glycogen causes progressive muscle weakness (myopathy) throughout the body and affects various body tissues, particularly in the heart, skeletal muscles, liver and nervous system.